April 2021

Isabel Fabregat receives a grant from the Ramón Areces Foundation to study liver fibrosis

The Ramón Areces Foundation has awarded Grants for Research in Life Sciences and Matter corresponding to its 20th edition. In ​​intercellular dialogue and interactome area, Dr. Isabel Fabregat, head of the research group “TGF-beta and cancer” at IDIBELL, in collaboration with Drs. Aránzazu Sánchez and Blanca Herrera from the Complutense University of Madrid, have received one of the grants.

Isabel Fabregat receives a grant from the Ramón Areces Foundation to study liver fibrosis Read More »

Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae

The work of the Epidemiology of Bacterial Infections research group of IDIBELL and HUB indicates that the bacteria could achieve the resistance through the acquisition of mobile DNA fragments.

Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae Read More »

Confirmed the presence of autoantibodies against type 1 interferon as an indicator of COVID-19 poor prognosis

A study led by IDIBELL and the Infanta Eleonor University Hospital in Madrid shows that 10% of patients with severe COVID-19 present neutralizing antibodies against the cytokine interferon type 1.

Confirmed the presence of autoantibodies against type 1 interferon as an indicator of COVID-19 poor prognosis Read More »

Created the largest public database of genetic variants that regulate the expression of genes in the colon to date

The study has also permitted identify genetic variants that modify the expression of genes in the colon and that are associated with diseases such as colorectal cancer, but also with other organs such as the brain, showing the relationship between the intestine and the brain.

Created the largest public database of genetic variants that regulate the expression of genes in the colon to date Read More »

Scroll to Top